Day One Biopharmaceuticals, Inc. — SCHEDULE 13G Filings
3 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Day One Biopharmaceuticals, Inc. (DAWN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Day One Biopharmaceuticals, Inc. has filed 3 SCHEDULE 13G documents with the SEC since 2021. To view all SEC filings by Day One Biopharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D9
SC TO-C
SC TO-T
SC TO-T/A
SC14D9C
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001076809-26-000031 | Mar 19, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-001078 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0002052113-25-003017 | Jul 17, 2025 | — |